EGFR and non-small cell lung carcinoma: <h4>Purpose</h4>To illustrate the regression of a metastatic lesion through ophthalmic imaging and correlating findings with standard chest imaging and treatment with osimertinib, an oral chemotherapy agent specific to Epidermal Growth Factor Receptor + Non-small Cell Lung Cancer (EGFR+ NSCLC).<h4>Case report</h4>A 63-year-old Asian male presented to ophthalmology with a complaint of left blurry vision.